Logo
Revolax Fine

Revolax Fine

Revolax

Dermal filler (medical device)
  • CE Marked Class III medical device (Revolax Fine with Lidocaine, along with Revolax Deep and Revolax Sub Q)
  • Manufactured under ISO 13485–compliant quality management system for medical devices
  • Produced according to Good Manufacturing Practice (GMP) standards
  • Non Animal Based, highly purified hyaluronic acid with very low endotoxin levels
  • Biodegradable monophasic HA filler intended for temporary improvement of facial wrinkles and superficial lines
Lightweight monophasic cross-linked hyaluronic acid dermal filler for superficial lines and fine wrinkles

Description

Revolax Fine with Lidocaine (1 x 1.1ml) is the lightest and most refined monophasic cross-linked hyaluronic acid dermal filler in the Revolax range, developed by Across Co., Ltd. It is formulated with highly purified, non-animal HA at 24 mg/ml and 0.3% lidocaine to ensure patient comfort. Designed for the correction of superficial lines and fine wrinkles, Revolax Fine is ideal for delicate areas such as crow’s feet, glabellar lines, forehead lines, perioral lines and neck wrinkles, and is also used in subtle lip work including Russian lip techniques. Its lightweight, high-viscoelasticity, crystal-clear gel integrates smoothly with skin tissue to deliver natural, long-lasting results typically lasting 8–12 months.

Bnefits

  • Thinnest and most refined filler in the Revolax range, ideal for superficial lines and delicate areas
  • Lightweight gel with high viscoelasticity for smooth, natural-looking correction
  • Biodegradable, non-animal-based, crystal-clear hyaluronic acid with very low endotoxin levels
  • Monophasic, cohesive gel structure for predictable placement and minimal migration
  • Contains 0.3% lidocaine to reduce injection discomfort and improve patient experience
  • Quickly integrates into the skin, creating a very natural and healthy appearance
  • Suitable for surface-level corrections and subtle volumisation without heaviness
  • CE-marked Class III medical device, legal for use in the UK and EU
  • Long-lasting effect, with most sources citing 8–12 months depending on area and patient factors

Indications

  • Superficial fine lines and wrinkles
  • Crow’s feet (periorbital fine lines)
  • Glabellar lines (frown lines) of superficial depth
  • Forehead lines
  • Perioral lines (smoker’s lines) and fine lines around the mouth
  • Neck wrinkles and fine platysmal lines
  • Delicate periorbital and periocular lines (as per practitioner protocol)
  • Subtle lip augmentation and contouring, including Russian lip techniques
  • Early signs of ageing in patients seeking natural, gentle enhancement

Composition

  • Cross-linked sodium hyaluronate (hyaluronic acid) 24 mg/ml
  • Lidocaine hydrochloride 0.3% for local anaesthetic effect and improved comfort
  • Non-animal, bio-fermentation–derived hyaluronic acid of high purity
  • BDDE (1,4-butanediol diglycidyl ether) as cross-linker in very minute residual quantity after purification
  • Physiological buffer solution and standard injectable excipients (sterile, pyrogen-free)

Formulation

  • Monophasic, crystal-clear cross-linked hyaluronic acid gel
  • Lightweight but high-viscoelasticity gel optimised for superficial injection
  • Biodegradable, non-animal-based HA with regular, dense lattice structure
  • Soft, cohesive gel designed for smooth injection and even distribution in superficial dermis
  • Sterile, pyrogen-free, single-use prefilled syringe formulation

Packaging

  • Box containing 1 x 1.1 ml prefilled glass syringe of Revolax Fine with Lidocaine
  • Typically supplied with 1 x 27G needle (Teleta) or 2 x 30G needles (some other distributors)
  • Instructions leaflet / Instructions for Use (IFU)
  • CE-marked Class III medical device packaging with batch number and expiry date

Usage

  • For professional use only; must be administered by appropriately trained and qualified medical or aesthetic practitioners.
  • Intended injection depth: superficial dermis for fine lines and surface-level wrinkle correction.
  • Common treatment sites include crow’s feet, glabellar lines, superficial forehead lines, perioral lines, neck wrinkles and selected delicate areas; it may also be used for subtle lip contouring and Russian lip techniques, according to practitioner protocol.
  • Use strict aseptic technique: disinfect the treatment area thoroughly and maintain sterility of syringe, needle and working environment.
  • Attach the supplied needle (commonly 27G or 30G depending on pack) and expel any air from the syringe before injection.
  • Inject slowly with minimal pressure using superficial techniques such as linear threading, serial puncture or micro-aliquot injections, tailored to the treatment area.
  • Avoid intravascular injection; aspirate in line with clinic protocol and monitor the patient continuously for signs of vascular compromise.
  • After injection, gently massage the treated area if necessary to ensure even distribution and a smooth surface.
  • Post-treatment, advise patients to avoid makeup on the treated area for several hours and to avoid intense exercise, alcohol consumption and exposure to extreme heat, cold or UV for at least 24 hours or as per clinic protocol.
  • Always refer to and follow the official Instructions for Use (IFU) provided with the product for full, manufacturer-approved guidance on indications, injection techniques, precautions and contraindications.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid, lidocaine or any excipient in the formulation
  • History of severe or multiple allergies or anaphylactic reactions unless fully evaluated and cleared by a physician
  • Presence of active skin infection, inflammation or dermatologic disease at or near the proposed injection site (e.g. herpes simplex, active acne, dermatitis)
  • Systemic infection or uncontrolled systemic illness where elective dermal filler treatment is deemed inappropriate
  • Autoimmune diseases or significant immunosuppression unless the risk–benefit has been individually assessed by the treating clinician
  • Pregnancy and breastfeeding (generally not recommended due to limited safety data)
  • Known tendency to hypertrophic or keloid scarring or significantly impaired wound healing
  • Use in patients under 18 years of age
  • Intended injection directly into blood vessels or in high-risk vascular regions without appropriate expertise and safety measures

Adverse Effects

  • Common, usually transient injection-site reactions: redness (erythema), swelling, tenderness, pain, itching, bruising or slight bleeding
  • Temporary small lumps, papules, nodules or mild irregularities that usually resolve spontaneously or with gentle massage or minor corrective measures
  • Localised infection or abscess formation if aseptic technique is not strictly followed
  • Immediate or delayed hypersensitivity or inflammatory reactions, including persistent swelling, erythema, induration or pruritus
  • Very rare but serious complications typical of HA fillers, such as vascular occlusion, tissue ischemia or necrosis, and visual disturbance or blindness if filler is inadvertently injected into an artery; these events require urgent specialist management
  • Any persistent, unusual or severe adverse event should be promptly evaluated and treated by an appropriately qualified medical professional

Storage Conditions

  • Store according to the manufacturer’s instructions on the outer carton; many sources specify controlled room temperature, typically in the range 2–25 °C or 15–32 °C.
  • Do not freeze.
  • Protect from direct sunlight and excessive heat.
  • Keep the syringe in its original sterile blister and carton until use to maintain sterility and traceability.
  • Do not use after the expiry date printed on the packaging or if the blister, syringe or carton appears damaged or previously opened.
  • Keep out of the reach of children.

Duration

Most clinical and distributor sources report Revolax Fine with Lidocaine lasts approximately 8\u201312 months, depending on the treatment area, injection technique, patient metabolism, lifestyle and skin condition.

Onset

Visible smoothing and improvement of superficial lines are immediate after injection, with optimal natural results apparent once any initial redness or swelling has resolved over the following days.

Browse more Dermal filler (medical device)

Top Treatments

Top Cities in the UK